Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.0154 | 1 | 1 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0073 | 0.3529 | 1 |
Mycobacterium ulcerans | thymidylate kinase | 0.0073 | 0.3529 | 0.5 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.0073 | 0.3529 | 0.5 |
Treponema pallidum | thymidylate kinase (tmk) | 0.0073 | 0.3529 | 0.5 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.0073 | 0.3529 | 0.5 |
Plasmodium vivax | thymidylate kinase, putative | 0.0073 | 0.3529 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0154 | 1 | 1 |
Toxoplasma gondii | thymidylate kinase | 0.0073 | 0.3529 | 0.5 |
Chlamydia trachomatis | thymidylate kinase | 0.0073 | 0.3529 | 0.5 |
Giardia lamblia | CDC8 | 0.0073 | 0.3529 | 0.5 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0154 | 1 | 1 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0073 | 0.3529 | 0.5 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0154 | 1 | 1 |
Entamoeba histolytica | Thymidylate kinase, putative | 0.0073 | 0.3529 | 0.5 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.0154 | 1 | 1 |
Leishmania major | thymidylate kinase-like protein | 0.0073 | 0.3529 | 1 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0073 | 0.3529 | 0.5 |
Plasmodium falciparum | thymidylate kinase | 0.0073 | 0.3529 | 0.5 |
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.0154 | 1 | 1 |
Mycobacterium tuberculosis | Thymidylate kinase Tmk (dTMP kinase) (thymidylic acid kinase) (TMPK) | 0.0073 | 0.3529 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | thymidylate kinase | 0.0073 | 0.3529 | 0.5 |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.0154 | 1 | 1 |
Mycobacterium leprae | probable thymidylate kinase Tmk (dTMP KINASE) (THYMIDYLIC ACID KINASE) (TMPK) | 0.0073 | 0.3529 | 0.5 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0073 | 0.3529 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 32.3 ug ml-1 | Cytotoxicity against human A549 cells after 48 hrs by MTT assay | ChEMBL. | 22578453 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.